BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33318292)

  • 1. Peculiar Phenotypic and Cytotoxic Features of Pulmonary Mucosal CD8 T Cells in People Living with HIV Receiving Long-Term Antiretroviral Therapy.
    Meziane O; Alexandrova Y; Olivenstein R; Dupuy FP; Salahuddin S; Thomson E; Orlova M; Schurr E; Ancuta P; Durand M; Chomont N; Estaquier J; Bernard NF; Costiniuk CT; Jenabian MA
    J Immunol; 2021 Feb; 206(3):641-651. PubMed ID: 33318292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of pulmonary mucosal cytotoxic CD8 T-cells in people living with HIV under suppressive antiretroviral therapy.
    Alexandrova Y; Yero A; Olivenstein R; Orlova M; Schurr E; Estaquier J; Costiniuk CT; Jenabian MA
    Respir Res; 2024 Jun; 25(1):240. PubMed ID: 38867225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression.
    Perdomo-Celis F; Velilla PA; Taborda NA; Rugeles MT
    PLoS One; 2019; 14(1):e0210540. PubMed ID: 30625227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Infection and Persistence in Pulmonary Mucosal Double Negative T Cells
    Meziane O; Salahuddin S; Pham TNQ; Farnos O; Pagliuzza A; Olivenstein R; Thomson E; Alexandrova Y; Orlova M; Schurr E; Ancuta P; Haddad É; Chomont N; Cohen EA; Jenabian MA; Costiniuk CT
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy.
    Costiniuk CT; Salahuddin S; Farnos O; Olivenstein R; Pagliuzza A; Orlova M; Schurr E; De Castro C; Bourbeau J; Routy JP; Ancuta P; Chomont N; Jenabian MA
    AIDS; 2018 Oct; 32(16):2279-2289. PubMed ID: 30102653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.
    Chiu CY; Chang JJ; Dantanarayana AI; Solomon A; Evans VA; Pascoe R; Gubser C; Trautman L; Fromentin R; Chomont N; McMahon JH; Cameron PU; Rasmussen TA; Lewin SR
    J Immunol; 2022 Jan; 208(1):54-62. PubMed ID: 34853078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.
    Christensen-Quick A; Massanella M; Frick A; Rawlings SA; Spina C; Vargas-Meneses M; Schrier R; Nakazawa M; Anderson C; Gianella S
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial recovery of senescence and differentiation disturbances in CD8
    Eberhard JM; Ahmad F; Hong HS; Bhatnagar N; Keudel P; Schulze Zur Wiesch J; Schmidt RE; Meyer-Olson D
    Clin Exp Immunol; 2016 Nov; 186(2):227-238. PubMed ID: 27377704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment.
    Cobos Jiménez V; Wit FW; Joerink M; Maurer I; Harskamp AM; Schouten J; Prins M; van Leeuwen EM; Booiman T; Deeks SG; Reiss P; Kootstra NA;
    J Infect Dis; 2016 Jul; 214(2):216-25. PubMed ID: 27073222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
    Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
    Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype, Polyfunctionality, and Antiviral Activity of
    Salido J; Ruiz MJ; Trifone C; Figueroa MI; Caruso MP; Gherardi MM; Sued O; Salomón H; Laufer N; Ghiglione Y; Turk G
    Front Immunol; 2018; 9():2443. PubMed ID: 30405632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proportion of CD57+ cells among effector CD8+ T cells is lower in HIV controllers compared with antiretroviral therapy-treated patients.
    Henriquez S; Lécuroux C; Bitu M; Avettand-Fenoel V; Churaqui F; Catalan P; Chéret A; Boufassa F; Saez-Cirion A; Monceaux V; Meyer L; Goujard C; Lambotte O; Bourgeois C;
    AIDS; 2019 Nov; 33(14):2137-2147. PubMed ID: 31688039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease.
    Popescu I; Drummond MB; Gama L; Lambert A; Hoji A; Coon T; Merlo CA; Wise RA; Keruly J; Clements JE; Kirk GD; McDyer JF
    J Infect Dis; 2016 Nov; 214(10):1520-1530. PubMed ID: 27613775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominance of weakly cytotoxic, T-bet
    Kiniry BE; Ganesh A; Critchfield JW; Hunt PW; Hecht FM; Somsouk M; Deeks SG; Shacklett BL
    Mucosal Immunol; 2017 Jul; 10(4):1008-1020. PubMed ID: 27827375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual T cell activation and skewed CD8+ T cell memory differentiation despite antiretroviral therapy-induced HIV suppression.
    Tanko RF; Soares AP; Masson L; Garrett NJ; Samsunder N; Abdool Karim Q; Abdool Karim SS; Riou C; Burgers WA
    Clin Immunol; 2018 Oct; 195():127-138. PubMed ID: 29883708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Low Frequency of IL-17-Producing CD8
    Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
    Front Immunol; 2018; 9():2502. PubMed ID: 30420859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection.
    Sakhdari A; Mujib S; Vali B; Yue FY; MacParland S; Clayton K; Jones RB; Liu J; Lee EY; Benko E; Kovacs C; Gommerman J; Kaul R; Ostrowski MA
    PLoS One; 2012; 7(7):e40146. PubMed ID: 22792231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of T Cell Exhaustion and Senescence and Their Relationship to Plasma TGF-β Levels in Treated HIV+ Immune Non-responders.
    Shive CL; Freeman ML; Younes SA; Kowal CM; Canaday DH; Rodriguez B; Lederman MM; Anthony DD
    Front Immunol; 2021; 12():638010. PubMed ID: 33868264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.